NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/04/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3.61 mln
Float1.24 mln
Earnings Date06/25/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
62
/ 100
Outperforming
Debt / Equity
0.06
Debt-free
ROE
-227
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Founded in 1984 and headquartered in San Diego, California, Aethlon Medical is working to bring a new kind of treatment device to patients fighting cancer or dangerous viral infections. The company's main product, the Hemopurifier, is currently in clinical trials and is also being explored for use in organ transplantation. By filtering harmful agents from the blood, this device aims to support the body's natural ability to fight disease.
